243 related articles for article (PubMed ID: 33589597)
1. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.
Zhang RY; Liu ZK; Wei D; Yong YL; Lin P; Li H; Liu M; Zheng NS; Liu K; Hu CX; Yang XZ; Chen ZN; Bian H
Signal Transduct Target Ther; 2021 Feb; 6(1):64. PubMed ID: 33589597
[TBL] [Abstract][Full Text] [Related]
2. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
[TBL] [Abstract][Full Text] [Related]
4. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
5. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
6. The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin.
Wang R; Fu Y; Yao M; Cui X; Zhao Y; Lu X; Li Y; Lin Y; He S
FEBS J; 2022 Oct; 289(20):6400-6419. PubMed ID: 35596723
[TBL] [Abstract][Full Text] [Related]
7. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
8. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.
Xiao K; Peng S; Lu J; Zhou T; Hong X; Chen S; Liu G; Li H; Huang J; Chen X; Lin T
Cell Death Dis; 2023 Jul; 14(7):408. PubMed ID: 37422473
[TBL] [Abstract][Full Text] [Related]
9. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.
Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q
Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235
[TBL] [Abstract][Full Text] [Related]
11. [High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
Chen H; Li Z; Wang M; Lu L; Tang Q; Luo L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):455-464. PubMed ID: 38597436
[TBL] [Abstract][Full Text] [Related]
12. SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle.
Dong G; Zhang S; Shen S; Sun L; Wang X; Wang H; Wu J; Liu T; Wang C; Wang H; Lu T; Rao B; Ren Z
Cell Death Dis; 2020 Oct; 11(10):837. PubMed ID: 33037180
[TBL] [Abstract][Full Text] [Related]
13. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
[TBL] [Abstract][Full Text] [Related]
15. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31.
Lv T; Jiang L; Kong L; Yang J
Oncol Rep; 2020 Mar; 43(3):953-964. PubMed ID: 32020206
[TBL] [Abstract][Full Text] [Related]
17. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
[TBL] [Abstract][Full Text] [Related]
20. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.
Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H
Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
